Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 401,590 | 397,433 | 453,932 | 331,696 | 132,838 |
| Receivables | 533,606 | 507,208 | 457,445 | 452,699 | 461,858 |
| Inventories | 379,958 | 390,599 | 380,282 | 393,974 | 395,141 |
| Other current assets | 213,458 | 206,733 | 203,595 | 205,861 | 189,188 |
| TOTAL | $1,528,612 | $1,501,973 | $1,495,254 | $1,384,230 | $1,179,025 |
| Non-Current Assets | |||||
| PPE Net | 708,178 | 708,725 | 702,177 | 687,101 | 683,270 |
| Intangibles | 518,833 | 524,024 | 450,461 | 448,895 | 455,138 |
| Other Non-Current Assets | 659,244 | 618,793 | 612,033 | 566,178 | 553,373 |
| TOTAL | $1,886,255 | $1,851,542 | $1,764,671 | $1,702,174 | $1,691,781 |
| Total Assets | $3,414,867 | $3,353,515 | $3,259,925 | $3,086,404 | $2,870,806 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 170,112 | 74,998 | 74,997 | 149,990 | 74,991 |
| Accounts payable and accrued liabilities | 117,468 | 117,462 | 110,643 | 112,609 | 107,664 |
| Accrued Expenses | 541,124 | 476,249 | 478,712 | 420,312 | 399,425 |
| TOTAL | $1,116,702 | $956,902 | $951,547 | $970,193 | $883,859 |
| Non-Current Liabilities | |||||
| Long Term Debt | 524,743 | 620,778 | 622,883 | 618,813 | 696,844 |
| Deferred Revenues | 37,998 | 38,193 | 37,195 | 37,282 | 37,779 |
| Other Non-Current Liabilities | 156,361 | 170,140 | 165,197 | 161,681 | 161,620 |
| TOTAL | $717,912 | $827,707 | $823,848 | $818,804 | $893,086 |
| Total Liabilities | $1,834,614 | $1,784,609 | $1,775,395 | $1,788,997 | $1,776,945 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,306 | 82,587 | 83,089 | 83,052 | 83,012 |
| Common Shares | 10,769 | 10,767 | 10,751 | 10,745 | 10,738 |
| Retained earnings | 4,883,448 | 4,680,150 | 4,444,571 | 4,250,050 | 4,037,819 |
| Other shareholders' equity | -79,415 | -74,760 | -65,357 | -69,412 | -67,893 |
| TOTAL | $1,580,253 | $1,568,906 | $1,484,530 | $1,297,407 | $1,093,861 |
| Total Liabilities And Equity | $3,414,867 | $3,353,515 | $3,259,925 | $3,086,404 | $2,870,806 |